IL-1 alpha

IL-1 alpha

IL-1 alpha 詳細

Molecule Name
Interleukin-1 alpha
分子の別称
IL1A,IL-1 ALPHA,IL1F1,IL1α
Drug Development Progress
治験薬の数11
市販薬剤の数1
研究&開発段階Approved
ターゲットの別称
Interleukin-1 Alpha,IL1A,IL1F1,IL-1 alpha,Interleukin 1 Alpha,Hematopoietin-1,Pro-Interleukin-1-Alpha,Preinterleukin 1 Alpha,IL1-ALPHA,IL-1A,IL1,Interleukin-1alpha
バックグランド
Interleukin-1 alpha (IL1a) is also known as IL-1A, IL1, IL1-ALPHA,IL1F1,and is a cytokine of the interleukin-1 family. IL1a possesses a wide spectrum of metabolic, physiological, haematopoietic activities, and plays one of the central roles in the regulation of the immune responses. It binds to the interleukin-1 receptor. IL-1α is constitutively produced by epithelial cells. It is found in substantial amounts in normal human epidermis and is distributed in a 1:1 ratio between living epidermal cells and stratum corneum.The constitutive production of large amounts of IL-1α precursor by healthy epidermal keratinocytes interfere with the important role of IL-1α in immune responses, assuming skin as a barrier, which prevents the entry of pathogenic microorganisms into the body. In vitro, IL-1α possesses biological effect on cells in the picomolar to femtomolar range. In vivo, Shortly after an onset of an infection into organism, IL-1α activates a set of immune system response processes.

IL-1 alpha 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
Tadekinig alfar-hIL-18BP; IL-18BPPhase 3 ClinicalAb2 Bio Ltd
Autoimmune Lymphoproliferative Syndrome; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation Syndrome
詳細
LutikizumabABT-981Phase 3 ClinicalAbbvie Inc
Colitis, Ulcerative; Crohn Disease; Dermatitis, Atopic; Hidradenitis Suppurativa; Osteoarthritis; Osteoarthritis, Knee
詳細
KPL-387KPL-387Phase 3 ClinicalKiniksa Pharmaceuticals Ltd
Heart Diseases; Pericarditis
詳細
BermekimabT2-18C3; RA-18C3; CV-18C3; CA-18C3; MABP-1; MABp1; JNJ-77474462; MAB-p1Phase 2 ClinicalXbiotech Inc
Acne Vulgaris; Colorectal Neoplasms; Dermatitis, Atopic; Diabetes Mellitus, Type 2; Digestive System Diseases; Eczema; Hematologic Neoplasms; Hidradenitis Suppurativa; Neoplasms; Psoriasis; Pyoderma Gangrenosum; Scleroderma, Systemic
詳細
ABBV-9832ABBV-9832Phase 2 ClinicalAbbvie Inc
Arthritis, Rheumatoid
詳細
ABBV-166ABBV-166Phase 2 ClinicalAbbvie Inc
Arthritis, Psoriatic; Crohn Disease
詳細
AC-701AC-701Phase 2 ClinicalTwi Pharmaceuticals Inc
Exanthema; Rosacea
詳細
VilamakitugXB-2001Phase 2 ClinicalXbiotech Inc
Arthritis, Rheumatoid; Axial Spondyloarthritis; Pancreatic Neoplasms; Rheumatic Diseases
詳細
CAN-10CAN-10Phase 1 ClinicalLund University Foundation
Myocarditis; Plaque psoriasis; Scleroderma, Systemic
詳細
GenSci-161GenSci-161Phase 1 ClinicalChangchun GeneScience Pharmaceuticals Co Ltd
Endometriosis; Hidradenitis Suppurativa
詳細
Interleukin-1-alpha targeting antibody (XBiotech)Phase 1 ClinicalXbiotech Inc
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
RilonaceptKPL-914; RGN-303ApprovedRegeneron Pharmaceuticals IncArcalyst, 炎朵United StatesCryopyrin-Associated Periodic SyndromesKiniksa Pharmaceuticals Ltd2008-02-27
Anemia; Arthritis, Juvenile; Atherosclerosis; Coronary Artery Disease; Cryopyrin-Associated Periodic Syndromes; Deficiency of interleukin-1 receptor antagonist; Diabetes Mellitus, Type 1; Familial Mediterranean Fever; Genetic Diseases, Inborn; Gout; Hearing Loss, Sensorineural; Inflammation; Muckle-Wells Syndrome (MWS); Pericarditis; Renal Insufficiency, Chronic; Sarcoidosis; Schnitzler Syndrome; Scleroderma, Diffuse; Scleroderma, Systemic; Still's Disease, Adult-Onset; Urticaria; Vascular Diseases
詳細